Cambridge Investment Research Advisors
BLUE

Cambridge Investment Research Advisors’s bluebird bio BLUE Stock Holding History

Cambridge Investment Research Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,052
Closed -$436K – 3104
2021
Q2 		$436K Sell
1,052
-36
-3% -$14.3K ﹤0.01% 2160
2021
Q1 		$425K Buy
1,088
+133
+14% +$65.5K ﹤0.01% 2015
2020
Q4 		$535K Sell
955
-604
-39% -$383K ﹤0.01% 1727
2020
Q3 		$1.09M Buy
1,559
+764
+96% +$596K 0.01% 1143
2020
Q2 		$629K Buy
795
+51
+7% +$38.5K ﹤0.01% 1419
2020
Q1 		$443K Buy
+744
New +$725K ﹤0.01% 1434
2019
Q2 		– Sell
-127
Closed -$258K – 2217
2019
Q1 		$258K Buy
+127
New +$224K ﹤0.01% 1899
2018
Q4 		– Sell
-127
Closed -$239K – 2168
2018
Q3 		$239K Buy
+127
New +$262K ﹤0.01% 1939
2018
Q2 		– Sell
-105
Closed -$233K – 2199
2018
Q1 		$233K Buy
+105
New +$267K ﹤0.01% 1857

Other funds holding BLUE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Cambridge Investment Research Advisors's BLUE Position: Q3 2021 in Review

Cambridge Investment Research Advisors sold out of bluebird bio (BLUE) in Q3 2021, closing a stake of 1,052 shares — an estimated $436K sold.

Cambridge Investment Research Advisors first reported a position in BLUE in Q1 2018 and held it in 9 quarters. The position peaked at $1.09M in Q3 2020. 196 funds tracked by Wall St. Rank hold BLUE as of Q3 2021.

  • Cambridge Investment Research Advisors reported no remaining bluebird bio position as of Q3 2021 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 1,052 bluebird bio shares in Q3 2021, an estimated $436K.
  • Cambridge Investment Research Advisors first reported a position in bluebird bio in Q1 2018 and held it in 9 quarters.
  • Cambridge Investment Research Advisors's bluebird bio position peaked at $1.09M in Q3 2020.
  • 196 funds tracked by Wall St. Rank held bluebird bio as of Q3 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.